1. Market Research
  2. > TheraCarb Inc. - Product Pipeline Review - 2013

TheraCarb Inc. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 24 pages

TheraCarb Inc. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “TheraCarb Inc. - Product Pipeline Review - 2013” provides data on the TheraCarb Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, TheraCarb Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from TheraCarb Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- TheraCarb Inc. - Brief TheraCarb Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TheraCarb Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of TheraCarb Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the TheraCarb Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate TheraCarb Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of TheraCarb Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the TheraCarb Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with TheraCarb Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of TheraCarb Inc. and identify potential opportunities in those areas.

Table Of Contents

TheraCarb Inc. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
TheraCarb Inc. Snapshot 4
TheraCarb Inc. Overview 4
Key Information 4
Key Facts 4
TheraCarb Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
TheraCarb Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
TheraCarb Inc. - Pipeline Products Glance 9
TheraCarb Inc. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
TheraCarb Inc. - Drug Profiles 11
Drug For AA Amyloidosis 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Drug For Alzheimer's Disease 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Drug For Clostridium Difficile Associated Diarrhea 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Drug For Escherichia coli 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Immunobait 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Vaccine for Vaginal Candidiasis 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
TheraCarb Inc. - Pipeline Analysis 17
TheraCarb Inc. - Pipeline Products by Therapeutic Class 17
TheraCarb Inc. - Pipeline Products By Target 19
TheraCarb Inc. - Pipeline Products by Route of Administration 20
TheraCarb Inc. - Pipeline Products By Mechanism of Action 21
TheraCarb Inc. - Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables

TheraCarb Inc., Key Information 4
TheraCarb Inc., Key Facts 4
TheraCarb Inc. - Pipeline by Indication, 2013 6
TheraCarb Inc. - Pipeline by Stage of Development, 2013 7
TheraCarb Inc. - Monotherapy Products in Pipeline, 2013 8
TheraCarb Inc. - Preclinical, 2013 9
TheraCarb Inc. - Discovery, 2013 10
TheraCarb Inc. - Pipeline By Therapeutic Class, 2013 18
TheraCarb Inc. - Pipeline By Target, 2013 19
TheraCarb Inc. - Pipeline By Route of Administration, 2013 20
TheraCarb Inc. - Pipeline Products By Mechanism of Action, 2013 21

List of Figures

TheraCarb Inc. - Pipeline by Indication, 2013 6
TheraCarb Inc. - Pipeline by Stage of Development, 2013 7
TheraCarb Inc. - Monotherapy Products in Pipeline, 2013 8
TheraCarb Inc. - Pipeline By Therapeutic Class, 2013 17
TheraCarb Inc. - Pipeline Products By Mechanism of Action, 2013 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.